← All companies
RTGN
RetinalGenix Technologies Inc.
$4.00
+0.00 0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$75.4M
Revenue (TTM)
—
Net income (TTM)
-$2.43M
EPS (TTM)
$-0.13
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$44.0
Total assets
$5.80K
Gross margin
—
52-week range
$3.20 – $4.01
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Changed accountants
Jul 15, 2026
10-Q
Quarter ended 2026-03-31
May 20, 2026
10-K
Fiscal year ended 2025-12-31
Apr 15, 2026
8-K
Director or officer change
Mar 26, 2026
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
10-Q/A
Quarter ended 2025-06-30
Aug 20, 2025
10-Q
Quarter ended 2025-06-30
Aug 19, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K
Entered a material agreement
Feb 20, 2025
10-Q
Quarter ended 2024-09-30
Nov 18, 2024
10-Q
Quarter ended 2024-06-30
Aug 19, 2024
10-Q
Quarter ended 2024-03-31
May 20, 2024
8-K
Other events
Apr 8, 2024
10-K
Fiscal year ended 2023-12-31
Apr 1, 2024
8-K
Director or officer change
Dec 6, 2023
8-K
Director or officer change; Other events
Dec 4, 2023
10-Q
Quarter ended 2023-09-30
Nov 14, 2023
10-Q
Quarter ended 2023-06-30
Aug 14, 2023
10-K/A
Fiscal year ended 2022-12-31
Jun 15, 2023
10-Q/A
Quarter ended 2023-03-31
May 30, 2023
10-Q
Quarter ended 2023-03-31
May 18, 2023
10-K
Fiscal year ended 2022-12-31
Mar 31, 2023
10-Q
Quarter ended 2022-09-30
Nov 17, 2022
10-Q
Quarter ended 2022-06-30
Aug 19, 2022
8-K
Director or officer change
Jul 28, 2022
8-K
Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Other events
Jul 7, 2022
10-Q/A
Quarter ended 2022-03-31
May 16, 2022
10-Q
Quarter ended 2022-03-31
May 13, 2022
10-K
Fiscal year ended 2021-12-31
Apr 15, 2022
8-K
Entered a material agreement
Feb 17, 2022
8-K
Entered a material agreement; Unregistered sale of equity
Dec 30, 2021
10-Q
Quarter ended 2021-09-30
Nov 22, 2021
Other filings
144
Jun 10, 2026
NT 10-Q
May 15, 2026
NT 10-K
Mar 30, 2026
144
Feb 25, 2026
144
Nov 7, 2025
NT 10-Q
Aug 14, 2025
144
Aug 12, 2025